Up to 20,000 patients in the UK are to be given medical cannabis over a two-year period in an initiative that aims to create the largest body of evidence on the drug in Europe.
An Australian trial which used a marijuana extract to treat 40 children with severe epilepsy found the drug has a manageable side effect profile, but only shows extensive symptom relief for a select number of patients.